Evaluating a new imaging technique for stroke treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the diagnostic benefits of flat-panel detector computed tomography perfusion imaging (FDCTP) in patients undergoing mechanical thrombectomy for acute ischemic stroke. The study will involve multiple centers and will focus on patients who either received thrombectomy or had diagnostic angiography due to the intention of treatment. By analyzing FDCTP images obtained during or after the procedure, the study seeks to determine how often this new imaging technique reveals clinically relevant information that could influence treatment decisions. The primary goal is to establish whether FDCTP can provide insights that are not visible through traditional 2D digital subtraction angiography.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Informed consent as documented by a signature
* The patients received mechanical thrombectomy or there was the intention to perform endovascular treatment, but only diagnostic angiography was performed.
* Patients received FDCTP as clinically indicated by the treating physician.

Exclusion Criteria:

* Inability to give consent due to insufficient knowledge of the project language
* Inability to follow the clinically indicated visit at 90 days after the index stroke (e.g. patients living abroad).

Where it's running

• University Hospital Bern
  Bern, Switzerland Recruiting
• University Hospital Basel
  Basel, Switzerland Not yet recruiting

Study contacts

• Principal investigator: Johannes Kaesmacher, Prof. — University of Bern
• Study coordinator: Johannes Kaesmacher, Prof.
• Email: nctu@insel.ch
• Phone: +41 31 66 4 05 38

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• NeuroAiD test in mild to moderate ischemic stroke patients

  This study tests whether adding MLC901 (NeuroAiD II) to standard stroke care helps adults who recently had an ischemic stroke recover better than standard care alone.

  Recruiting Phase 4 EVD Pharmacy and Medical Company Limited · Ho Chi Minh City · NCT07828210

• Intra-arterial Alteplase after successful reperfusion following mechanical thrombectomy

  This trial tests whether giving a small amount of alteplase directly into the artery after a successful thrombectomy helps adults with acute ischemic stroke recover better.

  Recruiting at 9 sites Phase 3 115 People's Hospital · An Giang and 12 other locations · NCT07727395

• Intra-arterial Thrombolysis After Endovascular Thrombectomy in AIS

  This trial tests whether giving intra-arterial thrombolysis with tenecteplase or alteplase after endovascular thrombectomy helps improve recovery in adults with acute ischemic stroke.

  Recruiting Phase 3 University of Calgary · Sydney, Barangaroo and 12 other locations · NCT07687056

• Early endovascular treatment for isolated internal carotid artery occlusion

  This trial tests whether giving early endovascular treatment, instead of best medical care alone, helps adults with acute ischemic stroke caused by an isolated internal carotid artery occlusion recover better.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang · NCT07016854

• IV tenecteplase given before clot removal for large-vessel ischemic stroke in the 4.5–24 hour window

  This trial tests whether a single IV dose of tenecteplase given before clot removal helps people with large-vessel ischemic stroke who arrive 4.5–24 hours after they were last well.

  Recruiting at 4 sites Phase 3 Xinqiao Hospital of Chongqing · Wuhan, Hubei and 3 other locations · NCT06987305

• Intra-arterial alteplase after successful reperfusion for anterior circulation ischemic stroke

  This trial tests whether giving intra-arterial alteplase after successful reperfusion improves 90-day functional outcomes for adults with anterior circulation large vessel occlusion stroke.

  Recruiting Phase 3 Central Hospital, Nancy, France · Nancy · NCT06768138

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.